Gabi Hanna
Principal investigator, leads LAMASSU PHARMA INC..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$4.2MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $4.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 6, 2026 | NIH | SBIR Phase II One Health Advancement of RABI-767 for the Management of Acute Pancreatitis | $866K | LAMASSU PHARMA INC. |
| Jun 23, 2025 | NIH | SBIR Phase II One Health Advancement of RABI-767 for the Management of Acute Pancreatitis | $867K | LAMASSU PHARMA INC. |
| Jun 25, 2024 | NIH | SBIR Phase II One Health Advancement of RABI-767 for the Management of Acute Pancreatitis | $874K | LAMASSU PHARMA INC. |
| Mar 30, 2021 | NIH | SBIR Phase II Development of a novel lipase inhibitor for the treatment of acute pancreatitis | $78K | LAMASSU PHARMA INC. |
| Jul 6, 2020 | NIH | SBIR Phase II Development of a novel lipase inhibitor for the treatment of acute pancreatitis | $1.5M | LAMASSU PHARMA INC. |
Peer ranks
Federal funding#362
Awards as PI#417
Patents#273
Companies
- LAMASSU PHARMA INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.